We have yet to fully define the immune responses associated with immunologic control of HIV replication. To develop an effective vaccine, we need to better understand the responses that may be controlling HIV, and why these defenses might fail. This study examines the T cell immune responses to HIV in naturally-infected subjects. It compares these responses with those generated against other viruses and non-viral pathogens in order to determine mechanisms of success or failure of an immune response.
|Ladell, Kristin; Hashimoto, Masao; Iglesias, Maria Candela et al. (2013) A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells. Immunity 38:425-36|
|Roux, Antoine; Mourin, Gisele; Fastenackels, Solene et al. (2013) CMV driven CD8(+) T-cell activation is associated with acute rejection in lung transplantation. Clin Immunol 148:16-26|
|Petrovas, Constantinos; Yamamoto, Takuya; Price, David A et al. (2013) High Production Rates Sustain In Vivo Levels of PD-1high Simian Immunodeficiency Virus-Specific CD8 T Cells in the Face of Rapid Clearance. J Virol 87:9836-44|
|Major, Eugene O; Douek, Daniel C (2013) Risk factors for rare diseases can be risky to define: PML and natalizumab. Neurology 81:858-9|
|Almeida, Jorge R; Sauce, Delphine; Price, David A et al. (2009) Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood 113:6351-60|
|Venturi, Vanessa; Price, David A; Douek, Daniel C et al. (2008) The molecular basis for public T-cell responses? Nat Rev Immunol 8:231-8|
|Price, David A; Bitmansour, Arlene D; Edgar, John B et al. (2008) Induction and evolution of cytomegalovirus-specific CD4+ T cell clonotypes in rhesus macaques. J Immunol 180:269-80|